We also conclude that urinary concentration of MMP-9, along with echocardiographic and clinical findings, may be helpful for predicting the natural course of VSD and, thus, assist in creating the best follow-up and therapy plan for each patient with this congenital heart defect. The gene discussed is MMP9; the disease is congenital heart disease.